ADSL and cancer: For instance, in order to predict AMPs and additional efficiencies towards, e.g., cancer cells and HIV, PseAAC was applied in a two-level approach: first, it was used to encode peptide sequences to distinguish between AMPs and non-AMPs and second, to determine additional effects.